One Patent Tossed, Two Upheld In Celebrex Appeal

Law360, New York (March 7, 2008, 12:00 AM EST) -- A federal appeals court handed down a split decision Friday in Teva Pharmaceuticals' challenge to Pfizer Inc.'s patents for its blockbuster arthritis drug Celebrex, upholding two of Pfizer's three disputed patents while tossing the third as invalid.

Teva had sought to overturn a lower court's ruling that its generic product had infringed on all three patents.

The U.S. Court of Appeals for the Federal Circuit decision, handed down Friday, bars Teva from launching a generic version of Celebrex in the U.S. until May 2014. Either party...
To view the full article, register now.